[go: up one dir, main page]

WO2008133206A1 - Vecteur de virus de paramyxoviridae non répliquant - Google Patents

Vecteur de virus de paramyxoviridae non répliquant Download PDF

Info

Publication number
WO2008133206A1
WO2008133206A1 PCT/JP2008/057609 JP2008057609W WO2008133206A1 WO 2008133206 A1 WO2008133206 A1 WO 2008133206A1 JP 2008057609 W JP2008057609 W JP 2008057609W WO 2008133206 A1 WO2008133206 A1 WO 2008133206A1
Authority
WO
WIPO (PCT)
Prior art keywords
gene
vector
replicating
sev
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/057609
Other languages
English (en)
Japanese (ja)
Inventor
Makoto Inoue
Hiroshi Ban
Mamoru Hasegawa
Yutaka Hanazono
Yukiko Kishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jichi Medical University
Dnavec Corp
Original Assignee
Jichi Medical University
Dnavec Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jichi Medical University, Dnavec Corp filed Critical Jichi Medical University
Publication of WO2008133206A1 publication Critical patent/WO2008133206A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18851—Methods of production or purification of viral material
    • C12N2760/18852—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Un vecteur SeV non répliquant (vecteur SeV/ΔP) peut être produit avec succès, lequel présente la délétion d'un gène pour la protéine P qui est une protéine constituant un RNP à partir de l'ARN génomique ou l'inactivation du gène. Il a été trouvé qu'un vecteur SeV qui a la délétion ou l'inactivation du gène P et porte un gène marqueur tel qu'un gène pour la GFP ou la luciférase peut être utilisé pour parvenir à un rendement de transfert élevé d'un gène étranger dans une cellule ou un rendement d'expression élevé d'un gène étranger dans une cellule. Il a également été découvert que le vecteur a une cytotoxicité réduite parce que le gène P est délété ou inactivé dans le vecteur pour provoquer la réduction de la quantité d'une protéine d'origine virale, exprimée dans une cellule hôte.
PCT/JP2008/057609 2007-04-19 2008-04-18 Vecteur de virus de paramyxoviridae non répliquant Ceased WO2008133206A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2007110547 2007-04-19
JP2007-110547 2007-04-19
JP2007-127421 2007-05-11
JP2007127421 2007-05-11

Publications (1)

Publication Number Publication Date
WO2008133206A1 true WO2008133206A1 (fr) 2008-11-06

Family

ID=39925660

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/057609 Ceased WO2008133206A1 (fr) 2007-04-19 2008-04-18 Vecteur de virus de paramyxoviridae non répliquant

Country Status (1)

Country Link
WO (1) WO2008133206A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010008054A1 (fr) * 2008-07-16 2010-01-21 ディナベック株式会社 Procédé de fabrication d'une cellule reprogrammée utilisant un vecteur viral chromosomiquement non intégré
WO2016125364A1 (fr) * 2015-02-02 2016-08-11 株式会社Ｉｄファーマ Vecteur viral à arn de polarité négative amélioré
US12252700B2 (en) 2015-11-13 2025-03-18 Id Pharma Co., Ltd. Paramyxovirus vector

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005065596A (ja) * 2003-08-25 2005-03-17 Japan Science & Technology Agency 増殖能欠損狂犬病ウイルス
WO2007007921A1 (fr) * 2005-07-13 2007-01-18 Kyushu University, National University Corporation Vecteur de mononégavirus recombinant de type génome fractionné

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005065596A (ja) * 2003-08-25 2005-03-17 Japan Science & Technology Agency 増殖能欠損狂犬病ウイルス
WO2007007921A1 (fr) * 2005-07-13 2007-01-18 Kyushu University, National University Corporation Vecteur de mononégavirus recombinant de type génome fractionné

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HANAZONO Y.: "Shinki Sendai Virus Vector o Mochiita Saitaiketsu Kansaibo Zofukuho no Kaihatsu", SHINKI SENDAI VIRUS VECTOR O MOCHIITA SAITAIKETSU KANSAIBO ZOFUKUHO NO KAIHATSU HEISEI 18 NENDO SOKATSU. BUNTAN KENKYU HOKOKUSHO, March 2007 (2007-03-01), pages 1 - 7 *
INOUE M.: "HoxB4 Idenshi o Tosao suru P Kessongata SeV Vector no Sakusei to Seino Hyoka ni Kansuru Kenkyu", SHINKI SENDAI VIRUS VECTOR O MOCHIITA SAITAIKETSU KANSAIBO ZOFUKUHO NO KAIHATSU HEISEI 18 NENDO SOKATSU. BUNTAN KENKYU HOKOKUSHO, March 2007 (2007-03-01), pages 8 - 11 *
MORIMOTO K.: "Virus Vector o Oyo shita Vaccine Kaihatsu Jinsokuka no Tameno Kibanteki Gijutsu Kaihatsu no Kenkyu", VIRUS VECTOR O OYO SHITA VACCINE KAIHATSU JINSOKUKA NO TAMENO KIBANTEKI GIJUTSU KAIHATSU NO KENKYU HEISEI 17 NENDO SOKATSU. BUNTAN KENKYU HOKOKUSHO, 2006, pages 1 - 15 *
WIEGAND M.A. ET AL.: "De novo synthesis of N and P proteins as a key step in Sendai virus gene expression", J. VIROL., vol. 81, no. 24, pages 13835 - 13844, XP002684869, DOI: doi:10.1128/JVI.00914-07 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010008054A1 (fr) * 2008-07-16 2010-01-21 ディナベック株式会社 Procédé de fabrication d'une cellule reprogrammée utilisant un vecteur viral chromosomiquement non intégré
US9127256B2 (en) 2008-07-16 2015-09-08 Dnavec Corporation Method for production of reprogrammed cell using chromosomally unintegrated virus vector
US9695445B2 (en) 2008-07-16 2017-07-04 Id Pharma Co., Ltd. Method for production of reprogrammed cell using chromosomally unintegrated virus vector
US11136594B2 (en) 2008-07-16 2021-10-05 Id Pharma Co., Ltd. Method for production of reprogrammed cell using chromosomally unintegrated virus vector
WO2016125364A1 (fr) * 2015-02-02 2016-08-11 株式会社Ｉｄファーマ Vecteur viral à arn de polarité négative amélioré
JPWO2016125364A1 (ja) * 2015-02-02 2017-11-30 株式会社Ｉｄファーマ 改良されたマイナス鎖ｒｎａウイルスベクター
JP2020195381A (ja) * 2015-02-02 2020-12-10 株式会社Ｉｄファーマ 改良されたマイナス鎖ｒｎａウイルスベクター
US12252700B2 (en) 2015-11-13 2025-03-18 Id Pharma Co., Ltd. Paramyxovirus vector

Similar Documents

Publication Publication Date Title
WO2022221359A8 (fr) Vaccins à arnm du virus d'epstein-barr
CA2860388C (fr) Vaccins bases sur le virus parainfluenza 5
HK1252144A1 (zh) 提高原代細胞中基於核酸內切酶的基因編輯
WO2011015656A3 (fr) Composition pour le traitement d'une infection par le virus de l'hépatite b
WO2008099189A3 (fr) Virus de l'herpès simplex et procédés de réplication virale
WO2003091401A3 (fr) Systeme multiplasmide de production de virus influenza
EP4484556A3 (fr) Compositions et procédés pour l'ingénierie in vitro du génome viral
WO2011082388A3 (fr) Vaccins à base d'adn infectieux contre le virus du chikungunya
HRP20211015T1 (hr) Cjepivo protiv citomegalovirusa (cmv)
WO2010102257A3 (fr) Procédés de clonage et de manipulation de génomes
WO2007002008A3 (fr) Procedes et compositions permettant d'exprimer un virus a arn sens negatif dans des cellules canines
AU2007240448A8 (en) Methods and compositions for expressing negative-sense viral RNA in canine cells
CL2012000452A1 (es) Acido nucleico infeccioso de virus torque teno porcino (pttv), que comprende secuencia que codifica un pttv infeccioso con una secuencia genomica de pttv 1a-va; acido nucleico, plasmido y celula hospedera que la comprenden; pttv infeccioso no virulento; vacuna.
WO2011048353A3 (fr) Construction
UA108902C2 (uk) Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
PH12015500499A1 (en) Recombinant measles virus expressing chikungunya virus polypeptides and their applications
WO2010118188A3 (fr) Production d'un virus intact dans un système cellulaire non hôte utilisant une construction virale hôte secondaire
ECSP10010375A (es) Paramixovirus oncolíticos atenuados que codifican citoquinas de aves
DK2431470T3 (da) DNase expression i rekombinante værtsceller
WO2010118205A3 (fr) Production d'un virus intact dans le système cellulaire (non hôte) d'un mammifère utilisant une construction virale hôte secondaire
WO2007047459A8 (fr) Compositions et procedes contre des virus rabiques
ZA202308362B (en) Hepatitis b vaccines and uses of the same
CN104195154B (zh) 新城疫病毒Mukteswar中等毒力疫苗株反向遗传操作系统及其应用
WO2008133206A1 (fr) Vecteur de virus de paramyxoviridae non répliquant
WO2012116253A3 (fr) Vaccin recombinant contre le virus des oreillons

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08751879

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08751879

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP